FR2100726A1 - - Google Patents
Info
- Publication number
- FR2100726A1 FR2100726A1 FR7120368A FR7120368A FR2100726A1 FR 2100726 A1 FR2100726 A1 FR 2100726A1 FR 7120368 A FR7120368 A FR 7120368A FR 7120368 A FR7120368 A FR 7120368A FR 2100726 A1 FR2100726 A1 FR 2100726A1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19702027645 DE2027645A1 (de) | 1970-06-05 | 1970-06-05 | Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2100726A1 true FR2100726A1 (US20040242566A1-20041202-C00021.png) | 1972-03-24 |
| FR2100726B1 FR2100726B1 (US20040242566A1-20041202-C00021.png) | 1975-10-10 |
Family
ID=5773104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7120368A Expired FR2100726B1 (US20040242566A1-20041202-C00021.png) | 1970-06-05 | 1971-06-04 |
Country Status (10)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003020280A2 (en) * | 2001-09-05 | 2003-03-13 | Minerva Biotechnologies Corporation | Compositions and use thereof in the treatment of cancer |
| US8349853B2 (en) | 2001-09-05 | 2013-01-08 | Minerva Biotechnologies Corporation | Compositions and methods of treatment of cancer |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4287341A (en) * | 1979-11-01 | 1981-09-01 | Pfizer Inc. | Alkoxy-substituted-6-chloro-quinazoline-2,4-diones |
| US6723727B1 (en) * | 1996-12-20 | 2004-04-20 | Hoechst Aktiengesellschaft | Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
| US5972929A (en) * | 1997-08-21 | 1999-10-26 | Shiseido Co., Ltd. | Quinazolinone derivative, hair growth promoter and external composition for skin using the same |
| WO2001025234A1 (en) * | 1999-10-01 | 2001-04-12 | Advanced Medicine, Inc. | Quinazolinones and analogues and their use as local anesthetics |
| US6667300B2 (en) | 2000-04-25 | 2003-12-23 | Icos Corporation | Inhibitors of human phosphatidylinositol 3-kinase delta |
| US6518277B1 (en) * | 2000-04-25 | 2003-02-11 | Icos Corporation | Inhibitors of human phosphatidylinositol 3-kinase delta |
| AUPR201600A0 (en) * | 2000-12-11 | 2001-01-11 | Fujisawa Pharmaceutical Co., Ltd. | Quinazolinone derivative |
| JP2005511581A (ja) * | 2001-11-07 | 2005-04-28 | メルク エンド カムパニー インコーポレーテッド | 有糸分裂キネシン阻害剤 |
| AUPS019702A0 (en) * | 2002-01-29 | 2002-02-21 | Fujisawa Pharmaceutical Co., Ltd. | Condensed heterocyclic compounds |
| EP1539180A4 (en) * | 2002-08-21 | 2006-08-30 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS AND METHODS |
| WO2004041755A2 (en) * | 2002-11-04 | 2004-05-21 | Nps Pharmaceuticals, Inc. | Quinazolinone compounds as calcilytics |
| ATE440825T1 (de) * | 2003-06-06 | 2009-09-15 | Vertex Pharma | Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern |
| WO2005016349A1 (en) * | 2003-08-14 | 2005-02-24 | Icos Corporation | Methods of inhibiting leukocyte accumulation |
| US20050043239A1 (en) * | 2003-08-14 | 2005-02-24 | Jason Douangpanya | Methods of inhibiting immune responses stimulated by an endogenous factor |
| RS55551B1 (sr) * | 2004-05-13 | 2017-05-31 | Icos Corp | Hinazolinoni kao inhibitori humane fosfatidilinozitol 3-kinaze delta |
| EP1755609A1 (en) * | 2004-05-25 | 2007-02-28 | Icos Corporation | Methods for treating and/or preventing aberrant proliferation of hematopoietic cells |
| WO2006089106A2 (en) * | 2005-02-17 | 2006-08-24 | Icos Corporation | Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation |
| US8349850B2 (en) * | 2006-03-28 | 2013-01-08 | Atir Holding S.A. | Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| US9492449B2 (en) | 2008-11-13 | 2016-11-15 | Gilead Calistoga Llc | Therapies for hematologic malignancies |
| US20100202963A1 (en) | 2008-11-13 | 2010-08-12 | Gallatin W Michael | Therapies for hematologic malignancies |
| AU2010229968A1 (en) | 2009-03-24 | 2011-10-13 | Gilead Calistoga Llc | Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
| ES2548253T3 (es) * | 2009-04-20 | 2015-10-15 | Gilead Calistoga Llc | Métodos para el tratamiento de tumores sólidos |
| BR112012001325A2 (pt) | 2009-07-21 | 2017-05-02 | Gilead Calistoga Llc | tratamento de distúrbios do fígado com inibidaores de pi3k |
| BRPI1003506B1 (pt) | 2010-09-24 | 2019-12-03 | Ache Int Bvi Ltd | composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a |
| EP3581567A1 (en) * | 2011-04-10 | 2019-12-18 | Atir Holding S.A. | Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| MX2014010656A (es) | 2012-03-05 | 2015-03-03 | Gilead Calistoga Llc | Formas polimorficas de (s)-2-(1-(9h-purin-6-ilamino)propil)-5-fluo ro-3-fenilquinazolin-4(3h)-ona. |
| IN2015MN00002A (US20040242566A1-20041202-C00021.png) | 2012-07-09 | 2015-10-16 | Lupin Ltd | |
| EP3083623A1 (en) | 2013-12-20 | 2016-10-26 | Gilead Calistoga LLC | Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one |
| AU2014364410B2 (en) | 2013-12-20 | 2017-11-16 | Gilead Calistoga Llc | Process methods for phosphatidylinositol 3-kinase inhibitors |
| NZ726360A (en) | 2014-06-13 | 2018-04-27 | Gilead Sciences Inc | Phosphatidylinositol 3-kinase inhibitors |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1053063A (US20040242566A1-20041202-C00021.png) * | 1963-05-18 |
-
1970
- 1970-06-05 DE DE19702027645 patent/DE2027645A1/de active Pending
-
1971
- 1971-05-28 US US05/148,100 patent/US3984555A/en not_active Expired - Lifetime
- 1971-06-01 AT AT244273A patent/AT317899B/de not_active IP Right Cessation
- 1971-06-01 AT AT470571A patent/AT318615B/de not_active IP Right Cessation
- 1971-06-01 AT AT244173A patent/AT318628B/de not_active IP Right Cessation
- 1971-06-02 CH CH450074A patent/CH558374A/xx not_active IP Right Cessation
- 1971-06-02 CH CH450174A patent/CH569732A5/xx not_active IP Right Cessation
- 1971-06-02 LU LU63267D patent/LU63267A1/xx unknown
- 1971-06-02 CH CH802071A patent/CH557829A/xx not_active IP Right Cessation
- 1971-06-03 CA CA114,709,A patent/CA951319A/en not_active Expired
- 1971-06-03 GB GB1880371*[A patent/GB1331522A/en not_active Expired
- 1971-06-04 FR FR7120368A patent/FR2100726B1/fr not_active Expired
- 1971-06-04 NL NL7107695A patent/NL7107695A/xx unknown
- 1971-06-04 BE BE768137A patent/BE768137A/xx unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1053063A (US20040242566A1-20041202-C00021.png) * | 1963-05-18 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003020280A2 (en) * | 2001-09-05 | 2003-03-13 | Minerva Biotechnologies Corporation | Compositions and use thereof in the treatment of cancer |
| WO2003020280A3 (en) * | 2001-09-05 | 2003-12-04 | Minerva Biotechnologies Corp | Compositions and use thereof in the treatment of cancer |
| US8349853B2 (en) | 2001-09-05 | 2013-01-08 | Minerva Biotechnologies Corporation | Compositions and methods of treatment of cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| AT318628B (de) | 1974-11-11 |
| NL7107695A (US20040242566A1-20041202-C00021.png) | 1971-12-07 |
| BE768137A (fr) | 1971-12-06 |
| CH557829A (de) | 1975-01-15 |
| CH558374A (de) | 1975-01-31 |
| CH569732A5 (US20040242566A1-20041202-C00021.png) | 1975-11-28 |
| GB1331522A (en) | 1973-09-26 |
| AT318615B (de) | 1974-11-11 |
| FR2100726B1 (US20040242566A1-20041202-C00021.png) | 1975-10-10 |
| AT317899B (de) | 1974-09-25 |
| US3984555A (en) | 1976-10-05 |
| DE2027645A1 (de) | 1971-12-09 |
| LU63267A1 (US20040242566A1-20041202-C00021.png) | 1972-08-23 |
| CA951319A (en) | 1974-07-16 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |